Compare IGC & SDEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IGC | SDEV |
|---|---|---|
| Founded | 2005 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.7M | 33.1M |
| IPO Year | 2005 | 2007 |
| Metric | IGC | SDEV |
|---|---|---|
| Price | $0.28 | $0.97 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $5.25 | N/A |
| AVG Volume (30 Days) | ★ 639.5K | 79.4K |
| Earning Date | 03-19-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 59.09 | 35.42 |
| EPS | N/A | ★ 2.77 |
| Revenue | ★ $1,271,000.00 | $370,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $13.06 | N/A |
| P/E Ratio | ★ N/A | $0.35 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.24 | $0.96 |
| 52 Week High | $0.50 | $1.60 |
| Indicator | IGC | SDEV |
|---|---|---|
| Relative Strength Index (RSI) | 56.92 | 38.97 |
| Support Level | $0.28 | N/A |
| Resistance Level | $0.31 | $1.27 |
| Average True Range (ATR) | 0.01 | 0.06 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 68.94 | 4.03 |
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.
Stablecoin Development Corp is an on-chain holding company focused on long-duration participation in protocol-aligned digital asset ecosystems. The Company's initial digital asset focus is the Sky protocol ecosystem, with SKY as its core holding. Through staking and other on-chain activities, the Company seeks to generate protocol-level economic returns while maintaining rigorous governance and risk management oversight.